Serum Vitamin D and Risk of Bladder Cancer (original) (raw)
Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Alison Mondul
Cancer Epidemiology, Biomarkers & Prevention, 2012
View PDFchevron_right
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
Yan Liu
2006
View PDFchevron_right
Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study
Alison Mondul
Cancer Epidemiology, Biomarkers & Prevention, 2011
View PDFchevron_right
Re: Prospective Study of Vitamin D and Cancer Mortality in the United States
Edward Gorham
JNCI Journal of the National Cancer Institute, 2008
View PDFchevron_right
Vitamin D Intake, Serum 25-hydroxyvitamin-D (25(OH)D) Levels, and Cancer Risk: a Comprehensive Meta-meta-analysis including Meta-analyses of Randomized Controlled Trials and Observational Epidemiological Studies
Yasemin baskın
View PDFchevron_right
Vitamin D Status and Cancer Incidence and Mortality: Something New Under the Sun
Gary Schwartz
JNCI Journal of the National Cancer Institute, 2006
View PDFchevron_right
The Role of Vitamin D in Cancer Prevention
Sharif Mohr
American Journal of Public Health, 2006
View PDFchevron_right
Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the Prostate testing for cancer and Treatment study (Gilbert)
Becky Gilbert
View PDFchevron_right
Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study
Bruce Hollis
JNCI Journal of the National Cancer Institute, 2008
View PDFchevron_right
Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
Edward Gorham
PLOS ONE, 2016
View PDFchevron_right
Vitamin D and Cancer Prevention
Hajo Zeeb
Current Nutrition Reports, 2012
View PDFchevron_right
Vitamin D3 Intake Dose and Common Cancer: A Population-Based Case Control Study in a Chinese Population
Chung-Feng Liu
Journal of Cancer, 2016
View PDFchevron_right
The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study
Katja Berger
Oncology Research and Treatment
View PDFchevron_right
Randomized controlled trials of vitamin D and cancer incidence: A modeling study
Barbara Boucher
PloS one, 2017
View PDFchevron_right
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis (Gilbert)
Becky Gilbert, C. Metcalfe
View PDFchevron_right
In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer
Jonathan Golledge, Zoë Hyde, Graeme Hankey, Leon Flicker
View PDFchevron_right
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study
Sarah Lewis
BMJ (Clinical research ed.), 2017
View PDFchevron_right
The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation
Steinar Tretli, Trude Robsahm
Cancers, 2013
View PDFchevron_right
Current progress in using vitamin D and its analogs for cancer prevention and treatment
Frank Lovicu
Expert Review of Anticancer Therapy, 2012
View PDFchevron_right
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis
C. Metcalfe
Cancer Causes & Control, 2011
View PDFchevron_right
Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer
MARÍA LUISA AGUERRI
The Journal of Steroid Biochemistry and Molecular Biology, 2004
View PDFchevron_right
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial 1,2
Ayomide Ogundeji
View PDFchevron_right
Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
Alison Mondul
International journal of epidemiology, 2016
View PDFchevron_right
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
sara gandini
Anti-Cancer Agents in Medicinal Chemistry- Anti-Cancer Agents), 2013
View PDFchevron_right
Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade (Gilbert)
Becky Gilbert
2012
View PDFchevron_right
Role of vitamin D supplementation for primary prevention of cancer: Meta-analysis of randomized controlled trials
Rizwan danish
Journal of Clinical Oncology
View PDFchevron_right
Serum Vitamin D and Risk of Prostate Cancer in a Case-Control Analysis Nested Within the European Prospective Investigation into Cancer and Nutrition (EPIC
Naomi Arguelles
2009
View PDFchevron_right
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
Trude Robsahm
Clinical Epidemiology
View PDFchevron_right
Vitamin D supplementation for prevention of cancer in adults
Christian Gluud
Reviews, 1996
View PDFchevron_right
Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case-control study
Ayla Acikgoz
Eastern Mediterranean Health Journal, 2020
View PDFchevron_right
Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention
Christine French
PubMed, 2011
View PDFchevron_right
Vitamin D for Cancer Prevention: Global Perspective
Edward Gorham
Annals of Epidemiology, 2009
View PDFchevron_right
WHO EMRO | Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers: a nested case–control study
Ayla Acikgoz
2020
View PDFchevron_right